Clinical Trials Browser

Lymphoma, B-Cell, Marginal Zone × axicabtagene ciloleucel × Clear all

NCT03105336 2025-12-23

ZUMA-5

Phase 2 Completed

159 enrolled 27 charts 1 FDA

Lymphoma, Follicular, Lymphoma, B-Cell, Marginal Zone